Predict Payer
Uptake Of New
Drugs With Precision

Strategic Launch Report

MMIT Strategic Launch Report provides drug manufacturers with a realistic view of payers’ coverage adoption rates and utilization management within the first year post-launch.

Use Strategic Launch Report to:

  • Predict one-year uptake of a pipeline agent
  • Outline payer and channel segmentation
  • Highlight potential obstacles from new drug launch policies
  • Inform speed of decision-making

Yes! I want to learn more about MMIT Strategic Launch Report

Strategic Launch Report Case Study

Strategic Launch Report Case Study

Strategic Launch Report

  • A trended multi-year summary of New to Market access
  • Categorized payers based on the “time to coverage” metric
  • Tools to give drug manufacturers confidence in predicting payer management for launch strategies

Additional Resources


Launch Readiness Assessment

Test your knowledge to see if you're prepared to predict one-year uptake of your new drug, outline payer and channel segmentation, and highlight potential obstacles from new drug launch policies.

MTE Session

Access Trends for Innovative Technology Cell and Gene Therapies, Biomarkers, and Telemedicine

Learn about access barriers to the use of innovative technology such as administrative burden and reimbursement challenges.


Related Solutions to Support Your Strategy

MMIT offers a variety of payer access data and insights solutions.